Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression

Cell Regulation
I LaxJ Schlessinger

Abstract

Cultured NIH-3T3 cells were transfected with cDNA constructs encoding human epidermal growth factor-receptor (EGF-R)* and two deletion mutants in the extracellular portion of the receptor molecule. One mutant is devoid of 124 amino-terminal amino acids, and the other lacks 76 residues. Mutant receptors were not delivered to the cell surface unless the transfected cells contained also endogenous EGF-Rs, suggesting that receptor interaction complements the mutation and allows surface display of mutant receptors. Immunoprecipitation experiments revealed an association between mutant and endogenous EGF-Rs when both proteins were expressed in the same cell. Hence, receptor-oligomers may exist in the plane of the membrane even in the absence of ligand binding, and oligomerization may play a role in normal trafficking of EGF-Rs to the cell surface. Mutant receptors retained partial ligand binding activity as 125I-labeled EGF was covalently cross-linked to both mutant receptors, and EGF stimulated, albeit weakly, their protein tyrosine kinase activity. Both mutant EGF-Rs bind EGF with a 10-fold lower affinity than that of the solubilized wild type EGF-R. These results provide further evidence that the region flanked by the two cysteine...Continue Reading

References

Mar 9, 1976·Biochemistry·R Koren, G G Hammes
Feb 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·A M Maxam, W Gilbert
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J SchlessingerI Pastan
Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H HaiglerS Cohen
Jan 1, 1979·Annual Review of Biochemistry·G Carpenter, S Cohen
Oct 1, 1986·The Journal of Cell Biology·C S CopelandA Helenius
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A M HoneggerJ Schlessinger
Jan 1, 1985·Annual Review of Biochemistry·T Hunter, J A Cooper
Dec 1, 1986·The Journal of Cell Biology·J Schlessinger
Jan 1, 1988·Annual Review of Biochemistry·Y Yarden, A Ullrich
Nov 1, 1988·Trends in Biochemical Sciences·J Schlessinger
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Böni-Schnetzler, P F Pilch
Jan 1, 1986·The Journal of Cell Biology·M C Zuniga, L E Hood
Jan 1, 1980·Journal of Supramolecular Structure·P S Linsley, C F Fox
Nov 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R ZidovetzkiT M Jovin
Jan 1, 1983·CRC Critical Reviews in Biochemistry·J SchlessingerY Yarden
Nov 24, 1983·Nature·I G Haas, M Wabl

❮ Previous
Next ❯

Citations

Jan 1, 1992·Biulleten' eksperimental'noĭ biologii i meditsiny·Iu D IvashchenkoA A Fil'chenkov
Apr 22, 2004·Journal of Immunological Methods·Jennifer R CochranK Dane Wittrup
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R L WoltjerJ V Staros
Jan 15, 1997·The EMBO Journal·M A LemmonJ Schlessinger
Mar 15, 2000·Protein Science : a Publication of the Protein Society·R N JorissenA W Burgess
Feb 26, 2008·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Lieven HuangTony Lahoutte
Oct 7, 2003·Molecular Cell·Antony W BurgessShigeyuki Yokoyama
Aug 16, 2016·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Kerrie HenniganJean McBryan
Apr 7, 2000·The American Journal of Pathology·V ViscoR Muraro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.